课题基金 / 基金详情

Role of angiotensin II receptor subtypes on cardiovascular remodeling induced by aortic banding

Role of angiotensin II receptor subtypes on cardiovascular remodeling induced by aortic banding
血管紧张素II受体亚型在主动脉束带诱导的心血管重塑中的作用
批准号:
14570669
负责人:
IWAI Masaru
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

IWAI Masaru的其他基金

相似基金

相关文献

中文摘要
翻译
腹主动脉缩窄可引起心肌肥厚,心肌重量增加,心肌细胞体积增大,冠状动脉壁增厚,冠状动脉周围纤维化。AT 2受体缺陷型(AT 2KO)小鼠心肌的变化与野生型(WT)小鼠相似,但冠状动脉的变化较野生型(WT)小鼠明显。AT 1受体阻断剂Valsartan可显著抑制WT和AT 2 KO小鼠的心脏重量和心肌细胞大小。缬沙坦对WT小鼠冠状动脉增厚和血管周围纤维化有抑制作用,但对AT 2KO小鼠的抑制作用较小。TUNEL、单链DNA和Hoechst 33342染色检测冠状动脉及血管周围组织细胞凋亡,Bax表达增加。AT 2KO小鼠的凋亡变化减少,但在WT小鼠中缬沙坦增加。从新生小鼠皮肤中分离和培养的成纤维细胞显示,血管紧张素(Ang)II增加胶原合成和TIMP-1表达。血管紧张素Ⅱ诱导的这些变化被缬沙坦抑制,但增强AT 2拮抗剂,PD 123319。Ang II抑制IGF-1诱导的AT 1 KO小鼠胶原合成和TIMT-1表达的增加。将酪氨酸磷酸酶显性失活突变体SHP-1转染成纤维细胞,可减弱Ang Ⅱ对AT 1 KO小鼠胶原合成的抑制作用,提示AT 2受体的激活可抵消AT 1受体的激活,抑制心肌肥厚时冠状动脉增厚和血管周围纤维化的改变。
英文摘要
The banding of abdominal portion of aorta induced cardiac hypertrophy accompanied with the increase in heart weight, cardiomyocyte size, coronary artery thickness and perivascular fibrosis of coronary artery. In AT2 receptor deficient (AT2KO) mice, the changes of cardiac muscle were similar to, but the changes of coronary artery were more exaggerated than in wild type (WT) mice. Valsartan, an AT 1 receptor blocker, significantly inhibited the heart weight and cardiomyocyte size both in WT and AT2KO mice. The coronary artery thickening and perivascular fibrosis were inhibited by valsartan in WT mice, but the inhibitory actions of valsartan were smaller in AT2KO mice. Apoptosis detected by TUNEL staining, single stand DNA and Hoechst33342, and Bax expression was increased in coronary artery and perivascular region. The apoptotic changes were decreased in AT2KO mice but increased by valsartan in WT mice. Fibroblasts isolated and cultured from neonatal mice skin showed an increase in collagen synthesis and TIMP-1 expression by angiotensin (Ang) II. These changes induced by Ang II were inhibited by valsartan but enhanced by AT2 antagonist, PD123319. Ang II inhibited the increase in collagen synthesis and TIMT-1 expression induced by IGF-1 in AT1KO mice. Transfection of dominant negative mutant of a tyrosine phsphatase, SHP-1, into fibroblast decreased the inhibitory actions of Ang II on collagen synthesis in AT1KO mice.These resukts suggest that AT2 receptor stimulation counter acts on the effects of AT 1 receptor stimulation to inhibit the changes of coronary artery thickening and perivascular fibrosis observed in cardiac hypertrophy.
期刊论文(106)
专著(0)
科研奖励(0)
会议论文
Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival following acute myocardial infarction in mice.
血管紧张素 II 2 型受体缺乏会加剧小鼠急性心肌梗死后的心力衰竭并降低生存率。
DOI: --
发表时间: 2003
期刊: Circulation 107
影响因子: --
作者: [Adachi, Y., Saito, Y., Kishimoto, I., Harada, M., Kuwahara, K., et al.]
通讯作者: et al.
Horiuchi, M., Cui, T-X., Li, Z., Li, J-M., Nakagami, H., Iwai, M., et al.: "Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker valsartan on vascular neointimal formation."Circulation. 107. 106-112 (2003)
Horiuchi, M., Cui, T-X., Li, Z., Li, J-M., Nakagami, H., Iwai, M., et al.:“氟伐他汀增强选择性 AT1 受体阻断剂缬沙坦对血管新生内膜的抑制作用
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 27 条
    Role of AT2 Receptor on Insulin Resistance and Adipose Tissue Dysfunction in Atherosclerotic Mouse Model
    • 批准号:
      21590956
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      IWAI Masaru
    • 依托单位:
    Important Role of Angiotensin Receptor Subtype in Adipocyte Differentiation and Insulin Resistance
    • 批准号:
      18590992
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.48万
    • 财政年份:
      2006
    • 负责人:
      IWAI Masaru
    • 依托单位:
    Effects of neuroendocrine factors on the exaggeration of liver injury: Study using ex vivo and in vitro system
    • 批准号:
      12670496
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.38万
    • 财政年份:
      2000
    • 负责人:
      IWAI Masaru
    • 依托单位:
    Mechanism of hepatic sympathetic action on potentiating liver injury and the involvement of cytokines.
    • 批准号:
      08670180
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1996
    • 负责人:
      IWAI Masaru
    • 依托单位:
    国内基金
    海外基金
    T-cell Receptor信号通路调控基因的表达机制分子解析
    • 批准号:
      32570839
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2025
    • 负责人:
      范高峰
    • 依托单位:
    盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
    • 批准号:
      82372202
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      侯旭敏
    • 依托单位:
    GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
    • 批准号:
      82371652
    • 项目类别:
      面上项目
    • 资助金额:
      45.00万元
    • 批准年份:
      2023
    • 负责人:
      刘开江
    • 依托单位:
    多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
    • 批准号:
      82370797
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      陶弢
    • 依托单位: